These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8378841)

  • 21. [Effects of immunosuppressor and cytostatic agents on the extracellular matrix production during experimental neuropathies].
    Krivoshchapov LG; Pal'tseva EM
    Biull Eksp Biol Med; 1998 Nov; 126(11):584-7. PubMed ID: 9883376
    [No Abstract]   [Full Text] [Related]  

  • 22. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
    Opastirakul S; Chartapisak W
    J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome].
    Duman VL
    Ter Arkh; 2002; 74(6):39-41. PubMed ID: 12136481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D; Nazneen A; Taguchi T; Razzaque MS
    Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunodepressant drugs in the treatment of glomerulonephritis.
    Cameron JS
    J Ir Med Assoc; 1971 Sep; 64(419):466-7. PubMed ID: 5118862
    [No Abstract]   [Full Text] [Related]  

  • 26. Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: in vivo evidence for an immunologic danger signal.
    Lang A; Benke D; Eitner F; Engel D; Ehrlich S; Breloer M; Hamilton-Williams E; Specht S; Hoerauf A; Floege J; von Bonin A; Kurts C
    J Am Soc Nephrol; 2005 Feb; 16(2):383-91. PubMed ID: 15601747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of corticotherapy in the primary nephrotic syndromes in adults].
    Fries D; Brunat N; François B; Traeger J
    J Urol Nephrol (Paris); 1965 Sep; 71(9):714-27. PubMed ID: 5859056
    [No Abstract]   [Full Text] [Related]  

  • 29. Membranous nephropathy.
    Sherman RA; Dodelson R; Gary NE; Eisinger RP
    J Med Soc N J; 1980 Sep; 77(10):649-52. PubMed ID: 7003153
    [No Abstract]   [Full Text] [Related]  

  • 30. Membranous nephropathy associated with acute myeloid leukemia.
    Sahiner S; Ayli MD; Yüksel C; Oneç K; Abayli E
    Transplant Proc; 2004 Nov; 36(9):2618-9. PubMed ID: 15621104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2.
    Brown HJ; Lock HR; Wolfs TG; Buurman WA; Sacks SH; Robson MG
    J Am Soc Nephrol; 2007 Jun; 18(6):1732-9. PubMed ID: 17460147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The therapy of membranous glomerulopathy].
    Ratner MIa
    Ter Arkh; 1996; 68(4):86-8. PubMed ID: 9324807
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antimitotic drugs in the treatment of the nephrotic syndrome].
    Perlińska-Schnejder L; Gutka A
    Pol Tyg Lek; 1968 Sep; 23(34):1276-7. PubMed ID: 5722526
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
    Neverov NI; Stavrovskaia EV; Kolina IB; Shvetsov MIu; Zakharova EV; Shilov EM
    Ter Arkh; 2001; 73(6):37-40. PubMed ID: 11521519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
    Chen S; Liu Z; Chen H; Zhou H; Wang J; Li L
    Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulse therapy with methylprednisolone--a new perspective on treatment of steroid-resistant glomerulonephritis?].
    Sasinka M; Podracká L; Nyullassy S; Böör A; Roland R
    Cesk Pediatr; 1992 Jan; 47(1):4-8. PubMed ID: 1559276
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of indometacin for treating diffuse glomerulonephritis under experimental and clinical conditions.
    Vihert AM; Glezer GA; Megrelishvili RI; Ryff IM
    Arzneimittelforschung; 1973 Jul; 23(7):991-6. PubMed ID: 4800460
    [No Abstract]   [Full Text] [Related]  

  • 39. Alternatively spliced isoforms of fibronectin in immune-mediated glomerulosclerosis: the role of TGFbeta and IL-4.
    Baelde HJ; Eikmans M; van Vliet AI; Bergijk EC; de Heer E; Bruijn JA
    J Pathol; 2004 Nov; 204(3):248-57. PubMed ID: 15372454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytokines and extracellular matrix in experimental glomerulopathies].
    Bogomazova SIu; Gladskikh OP; Ivanov AA; Atakheev IB; Shilov EM; Gitel' EP; Pal'tsev MA
    Arkh Patol; 1997; 59(6):45-50. PubMed ID: 9483218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.